Added to YB: 2024-09-18
Pitch date: 2024-09-16
SDGR [bullish]
Schrödinger, Inc.
-42.57%
current return
Author Info
Company Info
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally.
Market Cap
$907.3M
Pitch Price
$20.06
Price Target
N/A
Dividend
N/A
EV/EBITDA
-4.35
P/E
-8.72
EV/Sales
2.43
Sector
Health Care Technology
Category
growth
What’s in the box? Schrödinger, Inc. $SDGR
SDGR: AI-driven drug discovery platform targeting $100-150B pharma R&D market. Q4 revenue up 32% YoY to $74M. 25+ drug pipeline, partnerships with big pharma. Valued at 8-10x P/S, in line with 25-30% growth SaaS. Funded for 18mo, $48M incoming from Morphic sale. Risks: slow big pharma adoption, biotech capital drought.
Read full article (4 min)